Ubs Asset Management Americas Inc Pliant Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 139,574 shares of PLRX stock, worth $424,304. This represents 0.0% of its overall portfolio holdings.
Number of Shares
139,574
Previous 117,937
18.35%
Holding current value
$424,304
Previous $1.32 Million
39.03%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PLRX
# of Institutions
174Shares Held
64.8MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$18.2 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$15.1 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$14.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$9.82 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$9.72 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $148M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...